Danimer Scientific, Inc.

NYSE:DNMR Stock Report

Market Cap: US$7.7m

Danimer Scientific Past Earnings Performance

Past criteria checks 0/6

Danimer Scientific's earnings have been declining at an average annual rate of -40.1%, while the Chemicals industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 1.9% per year.

Key information

-40.1%

Earnings growth rate

-23.2%

EPS growth rate

Chemicals Industry Growth12.9%
Revenue growth rate1.9%
Return on equity-52.6%
Net Margin-297.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts

May 21
News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts

Danimer Scientific, Inc. (NYSE:DNMR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

May 10
Danimer Scientific, Inc. (NYSE:DNMR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Broker Revenue Forecasts For Danimer Scientific, Inc. (NYSE:DNMR) Are Surging Higher

Apr 25
Broker Revenue Forecasts For Danimer Scientific, Inc. (NYSE:DNMR) Are Surging Higher

Danimer Scientific Is In Trouble

Nov 17

Danimer Scientific: It's Not Time To Buy

Sep 05

Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream

Jun 20

Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)

May 15
Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)

Danimer Scientific: Falling Momentum As Cash Burn Climbs

Dec 19

What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Nov 17
What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Danimer Scientific: Biodegradable Plastics Are Still Important

Sep 30

Revenue & Expenses Breakdown

How Danimer Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:DNMR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2437-1114122
30 Jun 2440-1305124
31 Mar 2445-1466126
31 Dec 2347-1557328
30 Sep 2351-1447528
30 Jun 2351-1997730
31 Mar 2350-1908131
31 Dec 2253-1808531
30 Sep 2256-1648933
30 Jun 2259-619729
31 Mar 226089425
31 Dec 2159-608220
30 Sep 2153-516414
30 Jun 2153-614110
31 Mar 2150-102249
31 Dec 2047-9177
30 Sep 2044-9157
30 Jun 2040-3146
31 Mar 2035-11155
31 Dec 1932-20175
31 Dec 1830075

Quality Earnings: DNMR is currently unprofitable.

Growing Profit Margin: DNMR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DNMR is unprofitable, and losses have increased over the past 5 years at a rate of 40.1% per year.

Accelerating Growth: Unable to compare DNMR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DNMR is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (4.8%).


Return on Equity

High ROE: DNMR has a negative Return on Equity (-52.55%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 07:43
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Danimer Scientific, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laurence AlexanderJefferies LLC
Charles NeivertPiper Sandler Companies
Jeffrey OsborneTD Cowen